日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Safety and Pharmacokinetics of Glecaprevir/Pibrentasvir in Adults With Chronic Genotype 1-6 Hepatitis C Virus Infections and Compensated Liver Disease

格卡瑞韦/哌仑他韦在患有慢性基因1-6型丙型肝炎病毒感染和代偿性肝病的成人中的安全性和药代动力学

Gane, Edward; Poordad, Fred; Zadeikis, Neddie; Valdes, Joaquin; Lin, Chih-Wei; Liu, Wei; Asatryan, Armen; Wang, Stanley; Stedman, Catherine; Greenbloom, Susan; Nguyen, Tuan; Elkhashab, Magdy; Wörns, Marcus-Alexander; Tran, Albert; Mulkay, Jean-Pierre; Setze, Carolyn; Yu, Yao; Pilot-Matias, Tami; Porcalla, Ariel; Mensa, Federico J

Glecaprevir/pibrentasvir for hepatitis C virus genotype 3 patients with cirrhosis and/or prior treatment experience: A partially randomized phase 3 clinical trial

格卡瑞韦/哌仑他韦治疗伴有肝硬化和/或既往治疗史的丙型肝炎病毒基因3型患者:一项部分随机3期临床试验

Wyles, David; Poordad, Fred; Wang, Stanley; Alric, Laurent; Felizarta, Franco; Kwo, Paul Y; Maliakkal, Benedict; Agarwal, Kosh; Hassanein, Tarek; Weilert, Frank; Lee, Samuel S; Kort, Jens; Lovell, Sandra S; Liu, Ran; Lin, Chih-Wei; Pilot-Matias, Tami; Krishnan, Preethi; Mensa, Federico J

Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 2 hepatitis C virus infection

格卡瑞韦/哌仑他韦治疗日本慢性基因2型丙型肝炎病毒感染患者的疗效和安全性

Toyoda, Hidenori; Chayama, Kazuaki; Suzuki, Fumitaka; Sato, Ken; Atarashi, Tomofumi; Watanabe, Tsunamasa; Atsukawa, Masanori; Naganuma, Atsushi; Notsumata, Kazuo; Osaki, Yukio; Nakamuta, Makoto; Takaguchi, Koichi; Saito, Satoru; Kato, Koji; Pugatch, David; Burroughs, Margaret; Redman, Rebecca; Alves, Katia; Pilot-Matias, Tami J; Oberoi, Rajneet K; Fu, Bo; Kumada, Hiromitsu

Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis

格卡瑞韦/哌仑他韦治疗伴或不伴肝硬化的日本慢性基因1型丙型肝炎病毒感染患者的疗效和安全性

Chayama, Kazuaki; Suzuki, Fumitaka; Karino, Yoshiyasu; Kawakami, Yoshiiku; Sato, Ken; Atarashi, Tomofumi; Naganuma, Atsushi; Watanabe, Tsunamasa; Eguchi, Yuichiro; Yoshiji, Hitoshi; Seike, Masataka; Takei, Yoshiyuki; Kato, Koji; Alves, Katia; Burroughs, Margaret; Redman, Rebecca; Pugatch, David L; Pilot-Matias, Tami J; Krishnan, Preethi; Oberoi, Rajneet K; Xie, Wangang; Kumada, Hiromitsu

Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection

格卡瑞韦/哌仑他韦治疗既往接受过直接抗病毒药物治疗、严重肾功能损害或基因3型感染的日本丙型肝炎病毒感染患者的疗效和安全性

Kumada, Hiromitsu; Watanabe, Tsunamasa; Suzuki, Fumitaka; Ikeda, Kenji; Sato, Ken; Toyoda, Hidenori; Atsukawa, Masanori; Ido, Akio; Takaki, Akinobu; Enomoto, Nobuyuki; Kato, Koji; Alves, Katia; Burroughs, Margaret; Redman, Rebecca; Pugatch, David; Pilot-Matias, Tami J; Krishnan, Preethi; Oberoi, Rajneet K; Xie, Wangang; Chayama, Kazuaki

Correction to: Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection

更正:格卡瑞韦/哌仑他韦治疗既往接受过直接抗病毒药物治疗、严重肾功能损害或基因3型感染的HCV感染日本患者的疗效和安全性

Kumada, Hiromitsu; Watanabe, Tsunamasa; Suzuki, Fumitaka; Ikeda, Kenji; Sato, Ken; Toyoda, Hidenori; Atsukawa, Masanori; Ido, Akio; Takaki, Akinobu; Enomoto, Nobuyuki; Kato, Koji; Alves, Katia; Burroughs, Margaret; Redman, Rebecca; Pugatch, David; Pilot-Matias, Tami J; Krishnan, Preethi; Oberoi, Rajneet K; Xie, Wangang; Chayama, Kazuaki

Resistance characterization of hepatitis C virus genotype 2 from Japanese patients treated with ombitasvir and paritaprevir/ritonavir

对接受奥比他韦和帕瑞他韦/利托那韦治疗的日本患者的丙型肝炎病毒2型基因型进行耐药性特征分析

Schnell, Gretja; Tripathi, Rakesh; Krishnan, Preethi; Beyer, Jill; Reisch, Thomas; Irvin, Michelle; Dekhtyar, Tatyana; Setze, Carolyn; Rodrigues, Lino Jr; Alves, Katia; Burroughs, Margaret; Redman, Rebecca; Chayama, Kazuaki; Kumada, Hiromitsu; Collins, Christine; Pilot-Matias, Tami

Pooled Resistance Analysis in Patients with Hepatitis C Virus Genotype 1 to 6 Infection Treated with Glecaprevir-Pibrentasvir in Phase 2 and 3 Clinical Trials

在接受格卡瑞韦-哌仑他韦治疗的丙型肝炎病毒基因型 1 至 6 感染患者的 2 期和 3 期临床试验中进行的汇总耐药性分析

Krishnan, Preethi; Pilot-Matias, Tami; Schnell, Gretja; Tripathi, Rakesh; Ng, Teresa I; Reisch, Thomas; Beyer, Jill; Dekhtyar, Tatyana; Irvin, Michelle; Xie, Wangang; Larsen, Lois; Mensa, Federico J; Collins, Christine

Integrated Resistance Analysis of CERTAIN-1 and CERTAIN-2 Studies in Hepatitis C Virus-Infected Patients Receiving Glecaprevir and Pibrentasvir in Japan

日本接受格卡瑞韦和哌仑他韦治疗的丙型肝炎病毒感染患者的 CERTAIN-1 和 CERTAIN-2 研究综合耐药性分析

Preethi Krishnan, Gretja Schnell, Rakesh Tripathi, Jill Beyer, Thomas Reisch, Tatyana Dekhtyar, Michelle Irvin, Wangang Xie, Bo Fu, Margaret Burroughs, Rebecca Redman, Hiromitsu Kumada, Kazuaki Chayama, Christine Collins, Tami Pilot-Matias

Resistance Analysis of a 3-Day Monotherapy Study with Glecaprevir or Pibrentasvir in Patients with Chronic Hepatitis C Virus Genotype 1 Infection

慢性丙型肝炎病毒基因型 1 感染患者使用格卡瑞韦或哌仑他韦进行 3 天单药治疗研究的耐药性分析

Teresa I Ng, Tami Pilot-Matias, Rakesh Tripathi, Gretja Schnell, Preethi Krishnan, Thomas Reisch, Jill Beyer, Tatyana Dekhtyar, Michelle Irvin, Liangjun Lu, Armen Asatryan, Andrew Campbell, Betty Yao, Sandra Lovell, Federico Mensa, Eric J Lawitz, Jens Kort, Christine Collins